Evidence map›Paper›PMID 42542836›Full record

ArticleAnnals of internal medicine. Clinical cases2023

Euglycemic diabetic ketoacidosis related to SGLT2 inhibitor use in a patient with cobalamin C deficiency and diabetes.

Camilia L Kamoun, Jaclyn Tamaroff, Sanmati Cuddapah, Marc Yudkoff, Shana McCormack, Jessica I Gold

Abstract read
In one paragraph

Article in Annals of internal medicine. Clinical cases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Camilia L KamounDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA.
Jaclyn TamaroffDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA.
Sanmati CuddapahDivision of Human Genetics, Section of Biochemical Genetics, Children's Hospital of Philadelphia, Philadelphia, PA.
Marc YudkoffDivision of Human Genetics, Section of Biochemical Genetics, Children's Hospital of Philadelphia, Philadelphia, PA.
Shana McCormackDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA.
Jessica I GoldDivision of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA.

Funding

Translational Research Training in Pediatric Diabetes & EndocrinologyT32DK063688 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI LORRAINE E LEVITT KATZ, ANDREA Bridget KELLY · 2002 to 2026
$5.4M
NIDDK NIH HHS T32 DK063688
6 · The paper itself

Abstract

A 24-year-old female with cobalamin C deficiency (CblC), autoimmune thyroiditis, and recently diagnosed diabetes mellitus presented with weight loss, emesis, and abdominal pain. She had been placed on sodium-glucose cotransporter inhibitor (SGLT2i) therapy due to metformin intolerance, with the addition of a dipeptidyl peptidase-4 inhibitor. Biochemical analyses demonstrated severe acidosis, initially attributed to CblC-associated metabolic decompensation. Subsequent evaluation led to the diagnosis of SGLT2i-induced euglycemic diabetic ketoacidosis in a patient with insulin-dependent diabetes. This case highlights the importance of assessing for insulin deficiency when evaluating acidosis and the management challenges of common diseases in adults with inherited metabolic disorders.

Indexed as

anti-diabetic agentsAutoimmune diabetesCobalamin C deficiencydiabetic ketoacidosismetabolic diseaseSGLT2 Inhibitors

Identifiers

PMID42542836
PMCPMC13428637

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.